Instruction for use: Tenoten Kid

Dosage form: lozenges

Active substance: Antibodies to the brain-specific protein S-100

ATX

N05BX Other anxiolytics

Pharmacological groups:

Anxiolytics; Nootropics [Nootropics]

Anxiolytics; Nootropics [Anxiolytics]

The nosological classification (ICD-10)

F41.9 Anxiety disorder, unspecified: Neurotic disorders with anxiety syndrome; Severe anxiety; Neuro-like symptomatology; Neuro-like disorders; Neuro-like conditions; Neuroses with anxiety symptoms; Neuroses with a sense of anxiety; Acute situational and stress anxiety; Acute attack of anxiety; Severe Anxiety; Situational Anxiety Disorder; State of anxiety; Anxious and delusional component; Alarming state; Anxiety; Anxiety Disorders; Anxiety syndrome; Sense of anxiety; Alarm conditions; Chronic neurotic anxiety; Susto; Psychopathy with a predominance of anxiety and anxiety; Anxiety disorders in neurotic and neurosis-like states; Anxious neuroses; Anxious and delusional state; Acute situational stress alarm; Depressed mood with elements of anxiety

F48.9 Neurotic disorder, unspecified: Neurosis; Secondary neurotic symptom; Other neurotic conditions; Neurosis with increased irritability; Neuroses; Neuroses of all kinds; Neuroses with retardation; Neuroses of the heart; Neurotic disorders in alcoholism; Neurotic disorders with retardation; Neurotic disorders with anxiety syndrome; Neurotic reactions; Neurotic symptoms with alcoholism; Neurotic states; Neurotic syndrome; Neurotic disorder; Attack of neurological dysfunction; School neurosis; Emotional Stress

F90.0 Violation of activity and attention: Hyperactive child syndrome; Attention Deficit Disorder in Children; Hyperkinetic impulsive syndrome; Violation of attention with hyperactivity; attention deficit; Attention deficit in children; Difficulty concentrating; Concentration reduction; Violation of attention; Impaired concentration; Concentrating defect; Violation of mental activity; Violation of the ability to concentrate; Impairment of concentration; Violations of attention; Inability to concentrate; The weakening of attention; The weakening of the ability to concentrate; Decrease ability to concentrate; Reduced focus; disorders of attention; attention disorder; Attention Deficit Hyperactivity Disorder; Reduced attention; Reduced concentration; Decreased ability to concentrate

F91 Behavioral disorders: Juvenile and other behavioral disorders; Destructive behavior; Violation of behavior; Behavioral disorders; Mixed behavioral disorders; Behavioral Disorder; Behavioral disorder in adolescents with 15 years of age and adults; Violations in behavior; Behavioral disorders in childhood; Behavioral disorders in old age; Behavioral disorders in children; Behavior Disorder; Behavioral disorders in children

F93.9 Emotional disorder in childhood, unspecified: Neurotic syndrome in children

G90.9 Disorder of autonomic nervous system, unspecified: Asthenovegetative symptomatology; Asthenic-autonomic symptomatology; Asthenic autonomic disorder; Expressed autonomic responses; Nervous System Disorders; The defeat of the peripheral nervous system; Ganglionite; Sympathoglioniitis; Disease of the peripheral nervous system

R45.0 Nervousness: Stress nervous; Mental stress; State of tension; Stress states; Nervous disorders; Voltage; Tension; Psychoemotional stress; Stress state; Emotional tension; Feeling of inner tension; Psychoemotional stress in stressful situations; Nerve Stress Reactions; Internal stress; The state of persistent mental stress; Tearfulness

R45.1 Anxiety and agitation: Agitation; Anxiety; Explosive excitability; Internal stimulation; Excitability; Excitation; Excitation acute; Psychomotor agitation; Hyperexcitability; Motor excitement; Cessation of psychomotor agitation; Nervous excitement; Restlessness; Night trouble; Acute stage of schizophrenia with excitation; Acute mental agitation; Paroxysm of excitation; Overexcitation; Increased excitability; Increased nervous excitability; Increased emotional and cardiac excitability; Increased agitation; Mental arousal; Psychomotor agitation; Psychomotor agitation in psychoses; Psychomotor agitation of an epileptic nature; Psychomotor paroxysm; Psychomotor fit; Symptoms of excitation; Symptoms of psychomotor agitation; The state of agitation; A state of anxiety; Excitation status; A state of heightened concern; The state of psychomotor agitation; Conditions of anxiety; Excitation conditions; The state of excitement in somatic diseases; Excitation level; Feelings of anxiety; Emotional arousal

R45.4 Irritability and anger: Neurosis with increased irritability; Outbursts of anger; Anger; Resentment; Increased irritability; Increased irritability of the nervous system; Irritability; Irritability in neuroses; Irritability in psychopathic disorders; Symptoms of irritability; Dysphoria

Composition

Tablets for resorption 1 table.

active substance:

Antibodies to the brain-specific protein S-100 affinity purified * 0.003 g

* It is applied to lactose in the form of a water-alcohol mixture with a content of no more than 10-15 ng / g of the active form of the active ingredient

Auxiliary substances: MCC - 0.03 g; Magnesium stearate - 0.003 g; Lactose monohydrate (lactose) 0.267 g

Description of dosage form

Tablets are flat-cylindrical, with a risk and facet from white to almost white. On the side with the risk is the inscription "MATERIA MEDICA", on the other - "TENOTEN KID".

Pharmachologic effect

Mode of action - antidepressant, anti-asthenic, anxiolytic, nootropic, neuroprotective, antihypoxic, anti-stress, antiamnestic.

Pharmacodynamics

It has a calming, anti-anxious (anxiolytic) effect, without causing unwanted hypnogenic and muscle relaxant effects. It improves the tolerance of psychoemotional loads. Has a stress-protective, nootropic, anti-amnestic, antihypoxic, neuroprotective, anti-asthenic, antidepressant action.

In conditions of intoxication, hypoxia, after acute disturbance of cerebral circulation, it exerts a neuroprotective effect, limits the damage zone, normalizes learning and memory processes in the central nervous system.

Inhibits the processes of lipid peroxidation.

Modifies the functional activity of the S-100 protein, which conjugates the synaptic (information) and metabolic processes in the brain. Gamak-mimetic and neurotrophic action increases the activity of stress-limiting systems, promotes the restoration of neural plasticity processes.

Indication of the drug Tenoten Kid

Neurotic and neurosis-like disorders, accompanied by increased excitability, irritability, anxiety, behavioral and attention disorders, vegetative disorders;

Attention deficit hyperactivity disorder.

Contraindications

Increased individual sensitivity to the components of the drug;

Children's age till 3 years.

Side effects

When used at the indicated indications and in the recommended dosages, no side effect was detected. Possible reactions of increased individual sensitivity to the components of the drug.

Interaction

Cases of incompatibility with other drugs have not been recorded so far.

Dosing and Administration

Inside, not during a meal. For 1-2 table. At one time (keep in your mouth until completely dissolved). If necessary, the tablet can be dissolved in a small amount of boiled water at room temperature.

Neurotic and neurosis-like disorders. According to 1 table. 1-3 times a day. The course of treatment is 1-3 months; If necessary, the course of treatment can be extended to 6 months or repeat after 1-2 months.

Attention Deficit Hyperactivity Disorder. According to 2 tables. 2 times a day. The course of treatment - 1-3 months.

If there is no persistent improvement in the condition within 3-4 weeks after the start of treatment, you should see a doctor.

Overdose

There have been no cases of overdose to date.

Special instructions

The composition of the drug includes lactose, and therefore it is not recommended to appoint patients with congenital galactosemia, glucose malabsorption syndrome or galactose, or with congenital lactase deficiency.

In connection with the presence in the action of the drug Tenoten of children's activating properties, the last method is to exercise no later than 2 hours before bedtime.

Release form

Lozenges. For 20 tablets. In a planar cell packaging made of PVC film and aluminum foil. For 1, 2 or 5 contour cells are placed in a cardboard box.

Terms of leave from pharmacies

Without recipe.

Storage conditions of the drug Tenoten Kid

At temperatures not higher than 25 ° C, in the original packaging.

Keep out of the reach of children.

The shelf life of the drug Tenoten Kid

3 years.

Do not use beyond the expiration date printed on the package.